What's next for the weight-loss drug maker?
Shares in Danish biotech Zealand Pharma plunged recently after detailed data on its weight-loss drug survodutide showed much higher patient…
Health
Discover the Latest Health, Medicine, Nutrition, and Fitness Tips for Women, Men, and Children
The perennial and undefeated champions of the Tulsa Wii Bowling League
The team boards the bus outside their senior community in Tulsa, Oklahoma, wearing game-day T-shirts that feature an American flag…
In the midst of caring for children and elderly parents? Find resources
Being a family caregiver is hard work. On June 17, KFF Health News Midwest Correspondent Cara Anthony joined the WAMU…
Fermentation, flavor and the future of food: making sustainability delicious
At the Yondu Culinary Studio in Lower Manhattan, chef Jaume Biarnés demonstrates how to get rich, savory flavor from a…
US opens tariff investigation targeting Germany's drug pricing policies
The United States has launched an investigation into Germany's pharmaceutical policies over what it called “persistent underpayment” for drugs, as…
Ebola treatment capacity expands in DRC as WHO issues new guidelines
WHO has expanded isolation capacity for suspected cases and improved treatment facilities, including building individual isolation rooms that meet the…
Huntington's disease drug maker UniQure to seek FDA approval for gene therapy
Thomas Fuller | SOPA Images | Light rocket | fake images UniQure plans to seek FDA approval for its experimental…
Democrats seek to highlight rising healthcare costs by forcing vote on Trump regulation
In a move that mixes pure politics with flawed congressional procedures, Senate Democrats are seeking to force a vote to…
'Some wonder if Ebola is real': how trust is essential in the fight against the outbreak in the Democratic Republic of the Congo
Since the outbreak was declared on May 15, considerable progress has been made in testing capacity, Tarik Jašarević, spokesperson for…
Biotech IPO window is open, but big pharma M&As set the pace: bankers
Public markets are beginning to reopen for biotech companies after several years of subdued activity. But stronger companies are still…